<DOC>
	<DOCNO>NCT00206063</DOCNO>
	<brief_summary>The purpose study evaluate tolerability long-term treatment ximelagatran compare standard treatment warfarin .</brief_summary>
	<brief_title>Long Term Open Follow-up With H376/95 vs. Warfarin</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Ximelagatran</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Signed informed consent . Completion study SHTPA0002 , history chronic atrial fibrillation ( i.e . rapidly beat heart ) , least one risk factor stroke ( e.g . high blood pressure , age 65 , previous stroke similar attack , diabetes coronary heart disease ) Conditions associate increase risk bleeding , renal impairment , know active liver disease liver insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>